Showing results (11-20 of 162) with videos related to
Sort By:
Pageof 17
Diabetes Technology & Therapeutics|February 14, 2012
Dipeptidyl peptidase-4 inhibitors: 3 years of experienceGiuseppe Derosa, Pamela MaffioliCurrent Clinical Pharmacology|March 22, 2012
GLP-1 agonists exenatide and liraglutide: a review about their safety and efficacyGiuseppe Derosa, Pamela MaffioliExpert Opinion on Drug Safety|March 24, 2012
Anti-obesity drugs: a review about their effects and their safetyGiuseppe Derosa, Pamela MaffioliCurrent Molecular Pharmacology|November 30, 2011
Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists on glycemic control, lipid profile and cardiovascular riskGiuseppe Derosa, Pamela MaffioliNature Reviews. Endocrinology|July 30, 2014
Diabetes: safety and efficacy of albiglutide-results from two trialsGiuseppe Derosa, Pamela MaffioliClinical Therapeutics|May 8, 2012
Efficacy and safety profile evaluation of acarbose alone and in association with other antidiabetic drugs: a systematic reviewGiuseppe Derosa, Pamela MaffioliExpert Review of Cardiovascular Therapy|June 12, 2013
Assessment and management of left ventricular hypertrophy in Type 2 diabetes patients with high blood pressureGiuseppe Derosa, Pamela MaffioliPhytotherapy Research : PTR|January 30, 2020
Ilex paraguariensis, white mulberry and chromium picolinate in patients with pre-diabetesGiuseppe Derosa, Angela D'Angelo, Pamela MaffioliLife (Basel, Switzerland)|August 6, 2021
Metabolic Actions of a Supplement of Ilex Paraguariensis (An Extract of the Leaf Standardized to 2% I-Deoxinojirimcina), White Mulberry and Chromium Picolinate in Nondiabetic Subects with Dysglycemia: A Randomized TrialGiuseppe Derosa, Angela D'Angelo, Pamela MaffioliPharmacological Research|July 28, 2015
Sitagliptin in type 2 diabetes mellitus: Efficacy after five years of therapyGiuseppe Derosa, Angela D'Angelo, Pamela MaffioliPageof 17